Achaogen, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 41 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-10-11: Reporting owner Sarpangal Zeryn; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2018-10-11: Reporting owner Sarpangal Zeryn; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2018-10-11: Reporting owner Sarpangal Zeryn; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2018-10-11: Reporting owner Sarpangal Zeryn; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.89 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.99 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.65 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.65 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.34 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $23.62 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $23.62 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.64 exercise price | 2018-10-11 | ||
| 2018-10-11 holding as of filing | Sarpangal Zeryn Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.79 exercise price | 2018-10-11 | ||
| 2018-09-11 | Bhatt Elizabeth Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $4.79 exercise price | 2018-09-13 | |
| 2018-09-11 | Dorling Janet Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $4.79 exercise price | 2018-09-13 | |
| 2018-09-11 | LOEB GARY Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $4.79 exercise price | 2018-09-13 | |
| 2018-09-11 | Wise Blake Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +145,000 145,000 owned after | $4.79 exercise price | 2018-09-13 | |
| 2018-08-06 holding as of filing | Bhatt Elizabeth Officer (Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $16.18 exercise price | 2018-08-06 | ||
| 2018-08-06 holding as of filing | Bhatt Elizabeth Officer (Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $16.18 exercise price | 2018-08-06 | ||
| 2018-08-06 holding as of filing | Bhatt Elizabeth Officer (Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.64 exercise price | 2018-08-06 | ||
| 2018-08-06 holding as of filing | Bhatt Elizabeth Officer (Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.64 exercise price | 2018-08-06 | ||
| 2018-06-28 | Hillan Kenneth J. Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −132,727 0 owned after | $6.93 exercise price | 2018-06-29 | |
| 2018-06-28 | Hillan Kenneth J. Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −45,208 32,292 owned after | $3.65 exercise price | 2018-06-29 | |
| 2018-06-26 | Wise Blake Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,100 16,100 owned after | $10.64 exercise price | 2018-06-28 | |
| 2018-06-26 | Schilke Tobin Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $10.64 exercise price | 2018-06-28 | |
| 2018-06-26 | LOEB GARY Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,500 4,500 owned after | $10.64 exercise price | 2018-06-28 | |
| 2018-06-26 | Hillan Kenneth J. Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $10.64 exercise price | 2018-06-28 | |
| 2018-06-26 | Dorling Janet Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $10.64 exercise price | 2018-06-28 | |
| 2018-06-05 | Fischbach Michael Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | Lieginger Kent Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | Bernstein Karen Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | Smither John W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | DOYLE JOHN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | Gilbert Halley E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | STEA GREGORY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-06-05 | ROBERTS BRYAN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $12.07 exercise price | 2018-06-07 | |
| 2018-04-20 holding as of filing | Dorling Janet Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $23.68 exercise price | 2018-04-20 | ||
| 2018-04-20 holding as of filing | Dorling Janet Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $23.68 exercise price | 2018-04-20 | ||
| 2018-04-20 holding as of filing | Dorling Janet Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.64 exercise price | 2018-04-20 | ||
| 2018-02-08 | Wise Blake Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,800 22,800 owned after | $10.64 exercise price | 2018-05-15 | |
| 2018-02-08 | Schilke Tobin Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,000 32,000 owned after | $10.64 exercise price | 2018-05-15 | |
| 2018-02-08 | LOEB GARY Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $10.64 exercise price | 2018-05-15 | |
| 2018-02-08 | Swem Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $10.64 exercise price | 2018-05-15 | |
| 2018-02-08 | Hillan Kenneth J. Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $10.64 exercise price | 2018-05-15 | |
| 2018-01-01 | Wise Blake Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,000 106,000 owned after | $10.74 exercise price | 2018-01-03 |